Physician profile
Thomas T Lee
NPI 1942304373
$220.98
in general payments reported to CMS, 2019-2025
8 companies · $99.85 in 2025
The $99.85 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.89 · 2021: $31.23 · 2023: $23.05 · 2024: $25.96 · 2025: $99.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $47.80 | 2024-2025 | |
| Exeltis, USA INC. | $40.95 | 2025 | Slynd |
| Abbvie INC. | $40.89 | 2019 | |
| Hologic Sales and Service, LLC | $23.05 | 2023 | Aptima, Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $21.82 | 2025 | Gemtesa |
| Boston Scientific Corporation | $20.03 | 2021 | |
| Mayne Pharma Commercial LLC | $15.24 | 2025 | |
| Medicem INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.